UPDATE : Saturday, November 16, 2019
상단여백
Samsung Bioepis launches Enbrel biosimilar in Brazil by Lee Han-soo 2019-09-10 12:21
Method found to reduce adverse effects of bowel disease treatments by Lee Han-soo 2019-09-09 17:59
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’ by Lee Han-soo 2019-09-09 16:54
Invossa victims furious at government, Kolon for ‘doing nothing’ by Jeong Sae-im 2019-09-09 15:47
Hanmi to unveil investigator-led P2 progress for cancer treatment by Lee Han-soo 2019-09-09 15:47
라인
‘Micro blood vessel’s density can increase diagnostic accuracy of glaucoma’ by Lee Han-soo 2019-09-09 14:18
Novo Nordisk's Ryzodeg leads Korean mixed insulin market by Lee Han-soo 2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019 by Kim Yun-mi 2019-09-09 11:56
Ildong to sell GSK’s influenza treatment by Lee Han-soo 2019-09-06 17:02
Nobel laureate Honjo anticipates best combo in immunotherapies by Jeong Sae-im 2019-09-06 16:29
라인
Philadelphia Science Center to help Korean diagnostic firms enter US market by Lee Han-soo 2019-09-06 16:26
‘No antibiotic works for patients with multidrug-resistant infections’ by Kim Yun-mi 2019-09-06 15:11
Yuhan to expand biz scope to central nervous system disease by Jeong Sae-im 2019-09-06 14:56
Drug safety institute conducts APEC program by Lee Han-soo 2019-09-06 14:53
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan by Lee Han-soo 2019-09-05 17:04
라인
Lilly’s migraine treatment Emgality lands in Korea by Lee Hye-seon 2019-09-05 16:24
SNUBH researchers find new disease that causes acute dizziness by Lee Han-soo 2019-09-05 16:21
Korean doctors categorize 12 cases to refuse treatment by Song Soo-youn 2019-09-05 16:19
Daewoong, Medytox squabble over appraisal of additional spore for Nabota by Lee Han-soo 2019-09-05 14:35
SNUH to build smart clinical trial platform by Lee Han-soo 2019-09-05 14:35
여백
여백
여백
Back to Top